Myrbetriq (meer-BEH-trick, mirabegron) for overactive bladder

October 2012

Reps will rev up promotion of Myrbetriq (meer-BEH-trick, mirabegron) for overactive bladder.

They will point out that it's the first beta-3 agonist.

Beta-3 receptors play a role in relaxing smooth muscle...similar to beta-2 receptors. In the bladder, beta-3 agonists help relax the bladder and increase its storage capacity.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Hypertension debate about when to start drugs in patients with MILD hypertension
STIs Oral cefixime is no longer first-line for gonorrhea
Diabetes you'll hear MORE controversy about using pioglitazone (Actos) for type 2 diabetes
Infectious Diseases This will be the worst year yet for West Nile virus
Vaccines New virus strains in the 2012-2013 influenza vaccine
Statins whether statins increase the risk of cataracts
Overactive Bladder Myrbetriq (meer-BEH-trick, mirabegron) for overactive bladder
Respiratory & Allergy The new OTC bronchodilator Asthmanefrin (racepinephrine) will be promoted as an alternative to Primatene Mist (epinephrine)
Respiratory & Allergy whether inhaled corticosteroids inhibit growth in kids or increase fracture risk in seniors
Antipsychotics whether it makes sense to use more than one antipsychotic for schizophrenia
Depression more emphasis on treating depression in cardiac patients
Substance Use Disorder Patients are abusing Suboxone (buprenorphine/naloxone) tabs
Hepatitis C hepatitis C testing for ALL baby boomers

Myrbetriq (meer-BEH-trick, mirabegron) for overactive bladder

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents